Prescription ID | TCMF1179 |
Pinyin Name | Long Qing Pian |
Chinese Name | 癃清片 |
English Name | Long Qing Tablet |
Function Description | 热淋 |
Indications | Heat stranguria disorder, Acute prostatitis, Chronic prostatitis, Salmonella pyelonephritis, Chronic pyelonephritis, Cystitis, Urethritis |
Disease ICD-11 Category |
SA91 [Heat stranguria disorder (TM1), 热淋 (TM1)
]; GA91.Y [Other specified inflammatory and other diseases of prostate, 其他特指的前列腺炎性疾病 ]; GA91.0 [Chronic prostatitis, 慢性前列腺炎 ]; GC2Z [Diseases of the urinary system, unspecified, 泌尿系统疾病,未特指的 ]; GB55.Z [Chronic tubulo-interstitial nephritis, unspecified, 慢性肾小管-间质肾炎,未特指的 ]; GC00 [Cystitis, 膀胱炎 ]; GC02.Y [Other specified urethritis and urethral syndrome, 其他特指的尿道炎和尿道综合征 ]; |
Human Tissues Associated with Indication | Bladder |
Reference | Chinese pharmacopoeia (2015) |
Reference Book/link | ISBN 978-7-5067-7337-9 |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH2581 | Alisma orientale | 泽泻 | TCMH2581 | KC573871 |
TCMH241 | Plantago asiatica | 车前子 | TCMH241 | ITSAB3641-14 |
TCMH76 | Thlaspi arvense | 败酱草 | TCMH76 | MKPCH570-09 |
TCMH1127 | Lonicera japonica | 金银花 | TCMH1127 | ITSAI3881-14 |
TCMH1513 | Paeonia moutan | 牡丹皮 | TCMH1513 | |
TCMH71 | Oldenlandia diffusa | 白花蛇舌草 | TCMH71 | ITSAI3173-14 |
TCMH258 | Paeonia obovata | 赤芍 | TCMH258 | GBVX7902-15 |
TCMH2252 | Agrimonia pilosa var. japonica | 仙鹤草 | TCMH2252 | |
TCMH972 | Coptis chinensis | 黄连 | TCMH972 | ITSAO4469-14 |
TCMH949 | Phellodendron amurense | 黄柏 | TCMH949 | ITSAM1586-14 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT139 | CA6 | Carbonic anhydrase VI | Lyase | P23280 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT151 | PRKCA | Protein kinase C alpha | Kinase | P17252 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT187 | AR | Androgen Receptor | Nuclear receptor | P10275 |
TCMT189 | DUSP3 | Dual specificity protein phosphatase 3 | Hydrolase | P51452 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT240 | AMY1A | Salivary alpha-amylase | Unclassified | P04745 |
TCMT254 | CBR1 | Carbonyl reductase [NADPH] 1 | Oxidoreductase | P16152 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT27 | DRD1 | Dopamine D1 receptor | GPCR | P21728 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT33 | CYP3A4 | Cytochrome P450 3A4 | Oxidoreductase | P08684 |
TCMT337 | XPO1 | Exportin-1 | Unclassified | O14980 |
TCMT354 | AURKA | Serine/threonine-protein kinase Aurora-A | Kinase | O14965 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT377 | INSR | Insulin receptor | Kinase | P06213 |
TCMT38 | DRD2 | Dopamine D2 receptor | GPCR | P14416 |
TCMT384 | GRK6 | G protein-coupled receptor kinase 6 | Kinase | P43250 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT418 | EPHB4 | Ephrin type-B receptor 4 | Kinase | P54760 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT423 | EGFR | Epidermal growth factor receptor erbB1 | Kinase | P00533 |
TCMT436 | NUAK1 | NUAK family SNF1-like kinase 1 | Kinase | O60285 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT45 | APP | Beta amyloid A4 protein | Unclassified | P05067 |
TCMT457 | FLT4 | Vascular endothelial growth factor receptor 3 | Kinase | P35916 |
TCMT46 | F3 | Coagulation factor III | Unclassified | P13726 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT502 | TEK | Tyrosine-protein kinase TIE-2 | Kinase | Q02763 |
TCMT536 | PDGFRB | Platelet-derived growth factor receptor beta | Kinase | P09619 |
TCMT560 | F10 | Coagulation factor X | Unclassified | P00742 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT575 | PLA2G2A | Phospholipase A2 group IIA | Hydrolase | P14555 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT613 | NR3C1 | Glucocorticoid receptor | Nuclear receptor | P04150 |
TCMT626 | BRAF | Serine/threonine-protein kinase B-raf | Kinase | P15056 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT721 | HSPA1A | Heat shock 70 kDa protein 1 | Unclassified | P0DMV8 |
TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
TCMT739 | GPR35 | G-protein coupled receptor 35 | GPCR | Q9HC97 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT753 | SMAD3 | Mothers against decapentaplegic homolog 3 | Unclassified | P84022 |
TCMT755 | PLK4 | Serine/threonine-protein kinase PLK4 | Kinase | O00444 |
TCMT756 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Kinase | P41279 |
TCMT783 | NR3C2 | Mineralocorticoid receptor | Nuclear receptor | P08235 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
TCMT904 | PGR | Progesterone receptor | Nuclear receptor | P06401 |
Target ID | Target Name |
---|---|
TCMT1178 | Actinomyces viscosus |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1210 | Streptococcus sobrinus |
TCMT1211 | Fusobacterium nucleatum |
TCMT1212 | Verticillium dahliae |
TCMT1213 | Neisseria gonorrhoeae |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1218 | Staphylococcus aureus |
TCMT1221 | Human herpesvirus 4 |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1229 | Enterococcus faecalis |
TCMT1230 | Human herpesvirus 5 |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1236 | Mycobacterium bovis |
TCMT1246 | Escherichia coli |
TCMT1248 | Hepatitis C virus |
TCMT1249 | Dengue virus 2 |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1286 | Bacillus cereus |
TCMT1289 | Shigella dysenteriae |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1296 | Influenza A virus H3N2 |
TCMT1305 | Salmonella enteritidis |
TCMT1318 | Human T-lymphotropic virus 1 |
TCMT1321 | Staphylococcus hominis |
TCMT1343 | Staphylococcus simulans |
TCMT1344 | Staphylococcus sciuri |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1353 | Plasmodium yoelii |
TCMT1361 | Neisseria meningitidis |
TCMT1370 | Prevotella melaninogenica |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1385 | Candida shehatae |
TCMT1393 | Vibrio sp. |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1444 | Fusarium oxysporum |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1460 | Mycobacterium intracellulare |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 11.7485 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 11.7485 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALOX15, APP, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, NR3C1, PPARA, PRKCA, RORC, SMAD3, SRC, TEK, TYR | 10.5466 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TYR, XDH | 10.4807 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, APP, AR, CDC25B, CSNK2A1, CYP1B1, DRD2, EGFR, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PGR, PIM1, PRKCA, SMAD3, SRC, TEK, XDH | 10.1904 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CYP1B1, DRD2, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, PRKCA, PTPN1, SRC, TEK, XDH | 9.39561 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CSNK2A1, CYP1B1, DRD2, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 9.23684 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 9.23684 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PRKCA, PTPN1, SRC, TEK, XDH | 9.19783 |
[BP] GO:0042221 | response to chemical | AKR1B1, ALOX15, APP, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PPARA, PRKCA, RORC, SMAD3, SRC, TEK, TYR | 9.1956 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, APP, AR, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, FABP3, HSD17B2, IGF1R, INSR, MMP2, MMP9, NR3C1, PPARA, RORC, SRC, TEK, TYR | 9.09561 |
[BP] GO:0065008 | regulation of biological quality | ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, F10, F3, FABP3, FABP4, FLT3, GPR35, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, PPARA, PRKCA, SMAD3, SRC, TEK, XDH | 8.80157 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 | 8.80157 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PPARA | 8.79888 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TYR, XDH | 8.79888 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK | 8.55891 |
[BP] GO:0048518 | positive regulation of biological process | ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 8.3266 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK | 8.11555 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 8.05413 |
[BP] GO:0032879 | regulation of localization | ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK | 7.93359 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 7.93359 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA6, CA7, CA9 | 7.77522 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CSNK2A1, CYP1B1, DRD2, EGFR, F10, F3, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP2, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 7.67028 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK | 7.65113 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK | 7.6399 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, HSPA1A, PIM1, PPARA, TYR, XDH | 7.58097 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK | 7.21299 |
[BP] GO:0014070 | response to organic cyclic compound | APP, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, FLT3, NR3C1, RORC, SRC, TEK, TYR | 7.21143 |
[BP] GO:0030335 | positive regulation of cell migration | APP, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK | 7.16882 |
[BP] GO:0050896 | response to stimulus | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, F10, F3, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NR3C1, NUAK1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TYR | 7.13773 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, APP, AR, CA2, CA9, CSNK2A1, CYP1A2, DRD1, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, NR3C1, PPARA, SMAD3, SRC, TEK | 7.02974 |
[BP] GO:2000147 | positive regulation of cell motility | APP, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK | 7.01647 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PRKCA, PTPN1, SMAD3, SRC, TEK | 7.01647 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SRC | 6.98041 |
[BP] GO:0051272 | positive regulation of cellular component movement | APP, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK | 6.88062 |
[BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, ALOX15, APP, AR, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 6.7943 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, ALOX15, APP, AR, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 6.73837 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AR, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TYR, XDH | 6.73837 |
[BP] GO:0040017 | positive regulation of locomotion | APP, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK | 6.72564 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, FUT7, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PGR, PIM1, PPARA, PRKCA, RORC, SMAD3, SRC, TEK, TYR | 6.68966 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AR, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP4, HSD17B2, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TYR | 6.60103 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALOX15, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, RORC, SMAD3, SRC | 6.55466 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 6.55316 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK | 6.53515 |
[BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, ALOX15, APP, AR, DRD2, EGFR, FLT3, INSR, KDR, PRKCA, PTPN1, SRC, TEK, XDH | 6.51526 |
[BP] GO:0043408 | regulation of MAPK cascade | ADORA1, ALOX15, APP, AR, DRD2, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, PRKCA, PTPN1, SRC, TEK, XDH | 6.50197 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 6.4034 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, ALOX15, APP, AR, CDC25B, DRD1, DRD2, EGFR, FABP3, FLT3, INSR, KDR, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 6.37251 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, ALOX15, APP, AR, CDC25B, DRD1, DRD2, EGFR, FABP3, FLT3, INSR, KDR, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 6.37251 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MMP9, PIM1, PRKCA, PTPN1, SMAD3, SRC, TEK | 6.3448 |
[BP] GO:0051896 | regulation of protein kinase B signaling | AXL, DRD2, EGFR, F10, F3, INSR, MET, SRC, TEK, XDH | 6.27596 |
[BP] GO:0048583 | regulation of response to stimulus | ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 6.14604 |
[BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, AR, CDC25B, CSNK2A1, DRD2, EGFR, F3, FLT3, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, PRKCA, TEK | 6.13969 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AR, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TYR, XDH | 5.98189 |
[BP] GO:0080134 | regulation of response to stress | ADORA1, APP, CYP19A1, DRD2, DUSP3, EGFR, F3, FABP4, HSPA1A, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 5.96942 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALOX15, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, PTPN1, SRC, TEK, XDH | 5.89598 |
[BP] GO:0009966 | regulation of signal transduction | ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 5.87863 |
[BP] GO:0006468 | protein phosphorylation | APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK | 5.8071 |
[BP] GO:0042325 | regulation of phosphorylation | ADORA1, ALOX15, APP, AR, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, PRKCA, PTPN1, SRC, TEK, XDH | 5.77677 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, HSPA1A, IGF1R, KDR, MMP9, PIM1, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 5.77677 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALOX15, APP, AR, AXL, CYP1A1, CYP1B1, DRD1, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, NR3C1, RORC, SMAD3, SRC | 5.74821 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 5.74696 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PRKCA, PTPN1, SRC, TEK | 5.73821 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, HSD17B2 | 5.70969 |
[BP] GO:0001932 | regulation of protein phosphorylation | ADORA1, ALOX15, APP, AR, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PRKCA, PTPN1, SRC, TEK, XDH | 5.68416 |
[BP] GO:0033993 | response to lipid | AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, HSD17B2, NR3C1, RORC, SRC, TYR | 5.68021 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, FABP3, FABP4, FUT7, MET, PPARA | 5.68021 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 5.628 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALOX15, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, PTPN1, SRC, TEK, XDH | 5.58803 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 5.58298 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSD17B2, INSR, KDR, MMP9, PGR, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TYR | 5.54987 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, NUAK1, PTPN1, RORC, SMAD3, SRC | 5.50427 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, ALOX15, APP, AR, AURKB, CDC25B, DRD1, DRD2, EGFR, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 5.4548 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR | 5.44076 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 5.41195 |
[BP] GO:0031399 | regulation of protein modification process | ADORA1, ALOX15, APP, AR, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PRKCA, PTPN1, SRC, TEK, XDH | 5.3861 |
[BP] GO:0050790 | regulation of catalytic activity | ADORA1, ADORA3, APP, AR, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 5.37806 |
[BP] GO:0070372 | regulation of ERK1 and ERK2 cascade | ALOX15, APP, DRD2, DUSP3, EGFR, KDR, PRKCA, PTPN1, SRC, TEK | 5.37806 |
[BP] GO:0009893 | positive regulation of metabolic process | ADORA1, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 5.36276 |
[BP] GO:0009725 | response to hormone | AKR1B1, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, INSR, NR3C1, PPARA, SRC, TEK | 5.34604 |
[BP] GO:0048513 | animal organ development | ACHE, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, FLT3, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR | 5.24281 |
[BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK | 5.23257 |
[BP] GO:0065009 | regulation of molecular function | ADORA1, ADORA3, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 5.17952 |
[BP] GO:0051897 | positive regulation of protein kinase B signaling | AXL, EGFR, F10, F3, INSR, MET, SRC, TEK | 5.16306 |
[BP] GO:1901564 | organonitrogen compound metabolic process | ACHE, AKR1B1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, TYR, XDH | 5.11644 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, ALOX15, APP, AR, CDC25B, DRD2, EGFR, FLT3, INSR, KDR, MMP9, PRKCA, PTPN1, SRC, TEK, XDH | 5.066 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 | 4.92908 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, HSD17B1, HSD17B2, PRKCA | 4.82772 |
[BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, ALOX15, APP, AR, CDC25B, DRD2, EGFR, FLT3, INSR, KDR, MMP9, PRKCA, PTPN1, SRC, TEK, XDH | 4.82772 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX15, APP, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, TYR | 4.78361 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, EGFR, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK, TYR | 4.75539 |
[BP] GO:0015711 | organic anion transport | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD2, FABP3, PPARA | 4.75265 |
[BP] GO:0050678 | None | AR, EGFR, F3, KDR, MMP12, PGR, PRKCA, SMAD3, TEK, XDH | 4.716 |
[BP] GO:0016310 | phosphorylation | APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK | 4.716 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APP, AR, AXL, CYP1B1, DRD1, EGFR, IGF1R, INSR, MMP2, MMP9, NR3C1, RORC, SRC | 4.71077 |
[BP] GO:0051247 | positive regulation of protein metabolic process | ADORA1, ALOX15, APP, AR, CDC25B, CSNK2A1, DRD2, EGFR, F3, FLT3, HSPA1A, INSR, KDR, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 4.71077 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, HSPA1A | 4.6901 |
[BP] GO:0009611 | response to wounding | ACHE, ADORA3, ALOX15, CYP1A1, DRD2, EGFR, PPARA, SMAD3 | 4.68872 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APP, DRD1, DRD2, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR | 4.67327 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DRD2, DUSP3, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, PTPN1, SRC | 4.66206 |
[BP] GO:0050806 | positive regulation of synaptic transmission | ADORA1, APP, CA2, CA7, DRD1, DRD2, EGFR | 4.64695 |
[BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, ALOX15, AR, CYP19A1, DRD1, DRD2, DUSP3, EGFR, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 4.6043 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 | 4.59905 |
[BP] GO:0032101 | regulation of response to external stimulus | ADORA1, CYP19A1, DRD1, DRD2, EGFR, F3, FABP4, KDR, MET, MMP12, PPARA, PRKCA, SMAD3, TEK | 4.53565 |
[BP] GO:0071407 | cellular response to organic cyclic compound | APP, AR, CYP1A1, CYP1B1, DRD1, EGFR, FLT3, NR3C1, RORC, SRC | 4.51229 |
[BP] GO:0042592 | homeostatic process | ADORA1, AKR1B1, APP, AXL, CA12, CA2, CA7, DRD1, DRD2, EGFR, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC | 4.4723 |
[BP] GO:0051049 | regulation of transport | ACHE, ADORA1, ALOX15, APP, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, EGFR, GPR35, HSPA1A, INSR, MMP12, MMP9, PPARA, PRKCA, PTPN1, SMAD3, SRC | 4.46921 |
[BP] GO:0043401 | steroid hormone mediated signaling pathway | AR, NR3C1, NR3C2, PGR, PPARA, RORC, SRC | 4.46311 |
[BP] GO:0032270 | positive regulation of cellular protein metabolic process | ADORA1, ALOX15, APP, AR, CDC25B, DRD2, EGFR, F3, FLT3, HSPA1A, INSR, KDR, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 4.42869 |
[BP] GO:0070374 | positive regulation of ERK1 and ERK2 cascade | ALOX15, APP, DRD2, EGFR, KDR, PRKCA, SRC, TEK | 4.41729 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 4.41729 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 4.33102 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, APP, DRD1, DRD2, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR | 4.3189 |
[BP] GO:0045787 | positive regulation of cell cycle | APP, AURKB, CDC25B, CYP1A1, DRD2, DUSP3, EGFR, INSR, PRKCA, SRC | 4.3189 |
[BP] GO:0032268 | regulation of cellular protein metabolic process | ADORA1, ALOX15, APP, AR, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 4.21121 |
[BP] GO:0038083 | peptidyl-tyrosine autophosphorylation | EGFR, IGF1R, INSR, KDR, SRC | 4.18658 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, AR, DRD1, DRD2, DUSP3, EGFR, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, PTPN1, SMAD3, SRC, XDH | 4.14113 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, AR, DRD1, DRD2, DUSP3, EGFR, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, PTPN1, SMAD3, SRC, XDH | 4.12515 |
[BP] GO:0007166 | cell surface receptor signaling pathway | ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK | 4.05527 |
[BP] GO:0018193 | peptidyl-amino acid modification | AURKB, AXL, CSNK2A1, DRD1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, PRKCA, SRC, TEK | 4.00385 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 | 3.98048 |
[BP] GO:0051130 | positive regulation of cellular component organization | ALOX15, APP, AR, AURKB, AXL, DRD2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK | 3.96682 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP12, MMP2, MMP9, SRC, XDH | 3.95057 |
[BP] GO:0051701 | interaction with host | AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC | 3.95057 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 | 3.91841 |
[BP] GO:0010038 | response to metal ion | ALOX15, APP, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9 | 3.91841 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, HSD17B2, TYR, XDH | 3.91841 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.85206 |
[BP] GO:0007165 | signal transduction | ADORA1, ADORA3, AKR1B1, APP, AR, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK | 3.83181 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 | 3.82658 |
[BP] GO:0031401 | positive regulation of protein modification process | ADORA1, ALOX15, APP, AR, CDC25B, DRD2, EGFR, FLT3, INSR, KDR, MMP9, PRKCA, PTPN1, SRC, TEK, XDH | 3.81319 |
[BP] GO:0009755 | hormone-mediated signaling pathway | AR, NR3C1, NR3C2, PGR, PPARA, RORC, SRC | 3.81048 |
[BP] GO:0051240 | positive regulation of multicellular organismal process | APP, AR, AXL, CA2, CYP1B1, DRD2, EGFR, F3, HSPA1A, KDR, MET, MMP12, MMP9, PIM1, PRKCA, SMAD3, SRC, TEK | 3.79887 |
[BP] GO:0031347 | regulation of defense response | ADORA1, CYP19A1, DRD2, EGFR, FABP4, HSPA1A, MMP12, MMP2, PPARA, PTPN1, SMAD3, SRC, TEK | 3.78389 |
[BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR | 3.76708 |
[BP] GO:0006820 | anion transport | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD2, FABP3, PPARA | 3.76592 |
[BP] GO:0031348 | negative regulation of defense response | ADORA1, CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK | 3.75714 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC | 3.75358 |
[BP] GO:0050679 | None | AR, EGFR, F3, KDR, MMP12, PRKCA, TEK | 3.69756 |
[BP] GO:0030522 | intracellular receptor signaling pathway | AR, NR3C1, PGR, PIM1, PPARA, RORC, SRC | 3.69756 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2 | 3.69482 |
[BP] GO:0048878 | chemical homeostasis | AKR1B1, APP, CA12, CA2, CA7, DRD1, DRD2, EGFR, FABP3, FABP4, GPR35, INSR, MET, SMAD3 | 3.68875 |
[BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 3.68875 |
[BP] GO:1901654 | None | AKR1B1, AR, CA9, CSNK2A1, EGFR, NR3C1, SRC | 3.66002 |
[BP] GO:0071495 | cellular response to endogenous stimulus | AKR1B1, APP, AR, DRD1, EGFR, FLT3, IGF1R, INSR, MMP2, NR3C1, SMAD3, SRC | 3.66002 |
[BP] GO:0051246 | regulation of protein metabolic process | ADORA1, ALOX15, APP, AR, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH | 3.63715 |
[BP] GO:0001666 | response to hypoxia | ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK | 3.63623 |
[BP] GO:0080090 | regulation of primary metabolic process | ADORA1, ADORA3, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 3.63032 |
[BP] GO:0060255 | regulation of macromolecule metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 3.61514 |
[BP] GO:0031323 | regulation of cellular metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 3.58232 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK | 3.54744 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 | 3.51376 |
[BP] GO:0009987 | cellular process | ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TYR, XDH | 3.50092 |
[BP] GO:0043549 | regulation of kinase activity | ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PTPN1, SRC, TEK | 3.47634 |
[BP] GO:0034599 | cellular response to oxidative stress | AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC | 3.44045 |
[BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR | 3.4329 |
[BP] GO:0010634 | positive regulation of epithelial cell migration | KDR, MET, MMP9, PRKCA, SRC, TEK | 3.4329 |
[BP] GO:0051171 | regulation of nitrogen compound metabolic process | ADORA1, ADORA3, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 3.41431 |
[BP] GO:0032228 | regulation of synaptic transmission, GABAergic | ADORA1, CA2, CA7, DRD2 | 3.41431 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, NR3C1, SRC | 3.39672 |
[BP] GO:0048511 | rhythmic process | AXL, CSNK2A1, DRD2, EGFR, PGR, PPARA, RORC, SRC | 3.38067 |
[BP] GO:0051338 | regulation of transferase activity | ADORA1, APP, AURKB, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PTPN1, SRC, TEK | 3.37592 |
[BP] GO:0042493 | response to drug | AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, FABP3, KDR, NR3C1, SRC | 3.37592 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.37592 |
[BP] GO:0071383 | None | AR, EGFR, FLT3, NR3C1, SRC | 3.3408 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK | 3.31353 |
[BP] GO:0021885 | forebrain cell migration | AXL, DRD1, DRD2, EGFR | 3.27603 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, CA2, CA7, DRD1, DRD2, KDR, SRC | 3.27368 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA | 3.26549 |
[BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, EGFR | 3.22249 |
[BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, EGFR | 3.22249 |
[BP] GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | APP, AR, AURKB, DRD1, DRD2, EGFR, HSPA1A, IGF1R, INSR, MET, MMP12, NR3C1, PGR, PPARA, PTPN1, RORC, SMAD3, SRC | 3.19784 |
[BP] GO:1901655 | None | AKR1B1, AR, EGFR, NR3C1, SRC | 3.16977 |
[BP] GO:0045931 | positive regulation of mitotic cell cycle | APP, CDC25B, CYP1A1, DUSP3, INSR, PRKCA | 3.12564 |
[BP] GO:0009892 | negative regulation of metabolic process | ADORA1, APP, AR, AURKB, CSNK2A1, DRD2, DUSP3, EGFR, FABP4, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, XDH | 3.12564 |
[BP] GO:0044093 | positive regulation of molecular function | ADORA1, APP, AR, AURKB, CDC25B, DRD2, EGFR, F3, FLT3, HSPA1A, INSR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 3.12564 |
[BP] GO:0008283 | cell proliferation | ACHE, AR, AURKB, CYP1A1, EGFR, FLT3, MET, PIM1, SRC, TEK, TYR | 3.11102 |
[BP] GO:0045859 | regulation of protein kinase activity | ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PTPN1, SRC | 3.1025 |
[BP] GO:0019538 | protein metabolic process | ACHE, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, F10, F3, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK | 3.08759 |
[BP] GO:0007346 | regulation of mitotic cell cycle | APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, PRKCA, SMAD3 | 3.08759 |
[BP] GO:0071248 | cellular response to metal ion | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 | 3.07248 |
[BP] GO:0006950 | response to stress | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, HSPA1A, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK | 3.05769 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 3.04861 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 | 2.96544 |
[BP] GO:0051050 | positive regulation of transport | ACHE, ADORA1, APP, AXL, CA2, CYP19A1, DRD1, DRD2, EGFR, INSR, MMP12, SMAD3, SRC | 2.96025 |
[BP] GO:1903727 | positive regulation of phospholipid metabolic process | FABP3, FLT3, SRC, TEK | 2.96025 |
[BP] GO:0009891 | positive regulation of biosynthetic process | APP, AR, AURKB, DRD1, DRD2, EGFR, FABP3, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC | 2.9366 |
[BP] GO:0006367 | transcription initiation from RNA polymerase II promoter | AR, NR3C1, NR3C2, PGR, PPARA, RORC | 2.89817 |
[BP] GO:0048732 | gland development | AR, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR | 2.89817 |
[BP] GO:0016477 | cell migration | AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, SRC, TEK | 2.88457 |
[BP] GO:0043405 | regulation of MAP kinase activity | ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, PTPN1, SRC | 2.88416 |
[BP] GO:0071363 | cellular response to growth factor stimulus | APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC | 2.87095 |
[BP] GO:0006979 | response to oxidative stress | AKR1B1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC | 2.8603 |
[BP] GO:0048869 | cellular developmental process | ACHE, APP, AR, AXL, CBR1, CDC25B, CYP1A1, DRD1, DRD2, EGFR, FABP4, FLT3, FUT7, KDR, MET, MMP2, MMP9, PGR, RORC, SMAD3, SRC, TEK | 2.8266 |
[BP] GO:1901652 | response to peptide | AKR1B1, APP, FABP3, IGF1R, INSR, PPARA, SRC, TEK | 2.8097 |
[BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA3, APP, AR, AXL, CA2, CYP1B1, DRD2, EGFR, F3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PIM1, PRKCA, SMAD3, SRC, TEK, XDH | 2.79107 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 | 2.77747 |
[BP] GO:0000904 | cell morphogenesis involved in differentiation | AR, AXL, MET, SRC, TEK | 2.77747 |
[BP] GO:0051726 | regulation of cell cycle | APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DRD2, DUSP3, EGFR, HSPA1A, INSR, PIM1, PRKCA, SMAD3, SRC | 2.77341 |
[BP] GO:0001505 | regulation of neurotransmitter levels | ACHE, CYP1B1, DRD1, DRD2, EGFR, INSR, SMAD3 | 2.7733 |
[BP] GO:0065007 | biological regulation | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, GPR35, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 2.7723 |
[BP] GO:0051828 | entry into other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.7723 |
[BP] GO:0051806 | entry into cell of other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.7723 |
[BP] GO:0030260 | entry into host cell | AXL, EGFR, HSPA1A, MET, SRC | 2.7723 |
[BP] GO:0044409 | entry into host | AXL, EGFR, HSPA1A, MET, SRC | 2.7723 |
[BP] GO:0071241 | cellular response to inorganic substance | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 | 2.75749 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC | 2.73082 |
[BP] GO:0040011 | locomotion | AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MET, MMP1, MMP12, MMP9, SRC, TEK | 2.72756 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, AURKB, CA2, CA7, DRD1, DRD2, EGFR, KDR, SRC | 2.72554 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CYP1A1, FABP3, FLT3, PPARA, RORC, SRC, TEK | 2.71857 |
[BP] GO:0022414 | reproductive process | AKR1B1, APP, AR, AXL, CDC25B, CYP19A1, CYP1A1, DRD1, EGFR, HSD17B2, INSR, MMP2, MMP9, PGR, SRC | 2.70496 |
[BP] GO:0044089 | positive regulation of cellular component biogenesis | ALOX15, HSPA1A, KDR, MET, MMP1, PRKCA, SMAD3, SRC, TEK | 2.65416 |
[BP] GO:0097164 | None | ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2 | 2.63421 |
[BP] GO:0010638 | positive regulation of organelle organization | ALOX15, AURKB, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 2.63391 |
[BP] GO:0051893 | regulation of focal adhesion assembly | KDR, SMAD3, SRC, TEK | 2.62827 |
[BP] GO:0090109 | regulation of cell-substrate junction assembly | KDR, SMAD3, SRC, TEK | 2.62827 |
[BP] GO:0006807 | nitrogen compound metabolic process | ACHE, AKR1B1, AKR1B10, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TYR, XDH | 2.60371 |
[BP] GO:0060748 | None | AR, PGR | 2.59728 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.59728 |
[BP] GO:0032102 | negative regulation of response to external stimulus | ADORA1, CYP19A1, DRD1, DRD2, PPARA, SMAD3, TEK | 2.57181 |
[BP] GO:0032103 | positive regulation of response to external stimulus | EGFR, F3, FABP4, KDR, MET, PRKCA, SMAD3 | 2.57181 |
[BP] GO:0070848 | response to growth factor | APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC | 2.57181 |
[BP] GO:0001503 | ossification | ALOX15, EGFR, MMP2, MMP9, TEK | 2.55796 |
[BP] GO:0006805 | xenobiotic metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP3A4, RORC | 2.55796 |
[BP] GO:1903391 | regulation of adherens junction organization | KDR, SMAD3, SRC, TEK | 2.55247 |
[BP] GO:0048870 | cell motility | AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, SRC, TEK | 2.55208 |
[BP] GO:0002009 | morphogenesis of an epithelium | AR, CA2, CA9, EGFR, MET, SMAD3, SRC | 2.55012 |
[BP] GO:0050728 | negative regulation of inflammatory response | ADORA1, CYP19A1, PPARA, SMAD3, TEK | 2.54753 |
[BP] GO:0031328 | positive regulation of cellular biosynthetic process | APP, AR, AURKB, DRD1, DRD2, EGFR, FABP3, IGF1R, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC | 2.52441 |
[BP] GO:0043085 | positive regulation of catalytic activity | ADORA1, APP, AURKB, CDC25B, DRD2, EGFR, F3, FLT3, HSPA1A, INSR, PTPN1, SMAD3, SRC, TEK, XDH | 2.51024 |
[BP] GO:0051966 | regulation of synaptic transmission, glutamatergic | ADORA1, DRD1, DRD2, EGFR | 2.50812 |
[BP] GO:0071417 | cellular response to organonitrogen compound | AKR1B1, APP, DRD1, EGFR, IGF1R, INSR, MMP2, SRC | 2.50757 |
[BP] GO:0048871 | multicellular organismal homeostasis | ADORA1, AKR1B1, DRD1, DRD2, MET | 2.50757 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.50238 |
[BP] GO:0044267 | cellular protein metabolic process | APP, AR, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, PRKCA, PTPN1, SMAD3, SRC, TEK | 2.50238 |
[BP] GO:1902532 | negative regulation of intracellular signal transduction | DRD2, DUSP3, HSPA1A, IGF1R, MET, MMP9, PTPN1, SRC, XDH | 2.49596 |
[BP] GO:0050878 | regulation of body fluid levels | ADORA1, AKR1B1, DRD2, F10, F3, MET, PRKCA, XDH | 2.47854 |
[BP] GO:0051094 | positive regulation of developmental process | APP, AR, AXL, CA2, CYP1B1, DRD2, F3, INSR, KDR, PIM1, PRKCA, SMAD3, SRC, TEK | 2.47854 |
[BP] GO:0032989 | cellular component morphogenesis | APP, AR, AXL, DRD2, EGFR, MET, SRC, TEK | 2.47261 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, AXL, CYP1A1, CYP1B1, DRD1, DRD2, KDR, SRC | 2.46645 |
[BP] GO:0046486 | glycerolipid metabolic process | ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, MET | 2.45272 |
[BP] GO:0045834 | positive regulation of lipid metabolic process | FABP3, FLT3, PPARA, SRC, TEK | 2.43607 |
[BP] GO:0006352 | DNA-templated transcription, initiation | AR, NR3C1, NR3C2, PGR, PPARA, RORC | 2.40676 |
[BP] GO:0043393 | regulation of protein binding | APP, AURKB, MET, MMP9, PPARA, SRC | 2.40676 |
[BP] GO:0001775 | cell activation | ALOX5, APP, AXL, EGFR, FLT3, FUT7, HSPA1A, MMP9, PRKCA, RORC, SMAD3, SRC | 2.40272 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.3993 |
[BP] GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | CSNK2A1, F3, MMP9, SMAD3, SRC, XDH | 2.3993 |
[BP] GO:0050805 | negative regulation of synaptic transmission | ACHE, ADORA1, DRD1, DRD2 | 2.39812 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2 | 2.39756 |
[BP] GO:0050801 | ion homeostasis | APP, CA12, CA2, CA7, DRD1, DRD2, EGFR, FABP3, GPR35, SMAD3 | 2.39562 |
[BP] GO:0030155 | regulation of cell adhesion | ALOX15, CYP1B1, DUSP3, KDR, NUAK1, PPARA, PRKCA, SMAD3, SRC, TEK | 2.39562 |
[BP] GO:0090087 | None | ACHE, ADORA1, APP, CA2, DRD2, EGFR, MMP12, PRKCA, PTPN1, SMAD3, SRC | 2.39525 |
[BP] GO:0030574 | collagen catabolic process | MMP1, MMP12, MMP2, MMP9 | 2.38 |
[BP] GO:0032847 | regulation of cellular pH reduction | CA2, CA7 | 2.36959 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.36959 |
[BP] GO:0030198 | extracellular matrix organization | APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 | 2.36748 |
[BP] GO:0051894 | None | KDR, SMAD3, TEK | 2.36686 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.36686 |
[BP] GO:0010557 | positive regulation of macromolecule biosynthetic process | APP, AR, AURKB, DRD2, EGFR, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC | 2.36686 |
[BP] GO:0043062 | extracellular structure organization | APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 | 2.36403 |
[BP] GO:0033674 | positive regulation of kinase activity | ADORA1, CDC25B, DRD2, EGFR, FLT3, INSR, PTPN1, SRC, TEK | 2.34625 |
[BP] GO:0048609 | multicellular organismal reproductive process | AKR1B1, APP, AR, AXL, CYP1A1, DRD1, EGFR, PGR, SRC | 2.33544 |
[BP] GO:0051347 | positive regulation of transferase activity | ADORA1, AURKB, CDC25B, DRD2, EGFR, FLT3, INSR, PTPN1, SRC, TEK | 2.33458 |
[BP] GO:0010632 | regulation of epithelial cell migration | KDR, MET, MMP9, PRKCA, SRC, TEK | 2.3292 |
[BP] GO:0032872 | regulation of stress-activated MAPK cascade | APP, DUSP3, EGFR, IGF1R, PTPN1, XDH | 2.3292 |
[BP] GO:0050927 | None | F3, KDR, SMAD3 | 2.32482 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD17B1, HSD17B2 | 2.32482 |
[BP] GO:1901699 | cellular response to nitrogen compound | AKR1B1, APP, DRD1, EGFR, IGF1R, INSR, MMP2, SRC | 2.32482 |
[BP] GO:0070302 | regulation of stress-activated protein kinase signaling cascade | APP, DUSP3, EGFR, IGF1R, PTPN1, XDH | 2.32459 |
[BP] GO:0001936 | None | F3, KDR, PRKCA, TEK, XDH | 2.32369 |
[BP] GO:0009653 | anatomical structure morphogenesis | APP, AR, AXL, CA2, CA9, CYP1B1, DRD2, EGFR, INSR, MET, MMP2, SMAD3, SRC, TEK | 2.32369 |
[BP] GO:0030100 | regulation of endocytosis | ALOX15, APP, AXL, DRD2, PTPN1, SRC | 2.29668 |
[BP] GO:0048545 | response to steroid hormone | AR, CA2, EGFR, FLT3, NR3C1, SRC | 2.29668 |
[BP] GO:0007416 | None | ACHE, APP, DRD1, DRD2 | 2.2908 |
[BP] GO:0006706 | steroid catabolic process | CYP19A1, CYP1A2, CYP3A4 | 2.28752 |
[BP] GO:0050926 | None | F3, KDR, SMAD3 | 2.28752 |
[BP] GO:1903393 | None | KDR, SMAD3, TEK | 2.28752 |
[BP] GO:0051172 | None | APP, AR, AURKB, CSNK2A1, DRD2, DUSP3, EGFR, FABP4, HSPA1A, IGF1R, MMP12, MMP9, NR3C1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, XDH | 2.28358 |
[BP] GO:0001101 | response to acid chemical | AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC | 2.28042 |
[BP] GO:0006464 | cellular protein modification process | APP, AR, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, PTPN1, SMAD3, SRC, TEK | 2.27884 |
[BP] GO:0036211 | protein modification process | APP, AR, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, PTPN1, SMAD3, SRC, TEK | 2.27884 |
[BP] GO:0008285 | negative regulation of cell proliferation | ADORA1, ADORA3, APP, AR, CYP1B1, DRD2, FABP3, HSPA1A, SMAD3, XDH | 2.2694 |
[BP] GO:1903725 | regulation of phospholipid metabolic process | FABP3, FLT3, SRC, TEK | 2.25546 |
[BP] GO:0035556 | intracellular signal transduction | AKR1B1, AXL, CYP1B1, DRD1, DRD2, EGFR, IGF1R, INSR, KDR, MET, NUAK1, PRKCA, PTPN1, SRC, TEK | 2.24585 |
[BP] GO:0002682 | regulation of immune system process | ADORA1, ALOX15, APP, AXL, CA2, CYP19A1, DRD2, DUSP3, HSPA1A, MMP12, MMP2, PRKCA, PTPN1, SMAD3, SRC | 2.24388 |
[BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, DRD1, DRD2, EGFR | 2.24024 |
[BP] GO:0044243 | multicellular organismal catabolic process | MMP1, MMP12, MMP2, MMP9 | 2.23697 |
[BP] GO:0043412 | macromolecule modification | APP, AR, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NR3C1, NUAK1, PIM1, PRKCA, PTPN1, SMAD3, SRC, TEK | 2.22438 |
[BP] GO:0009968 | negative regulation of signal transduction | AR, DRD2, DUSP3, EGFR, HSPA1A, IGF1R, MET, MMP12, MMP9, PTPN1, SMAD3, SRC, XDH | 2.21994 |
[BP] GO:0016572 | histone phosphorylation | AURKB, DRD1, PRKCA | 2.20835 |
[BP] GO:0051128 | regulation of cellular component organization | ALOX15, APP, AR, AURKB, AXL, CSNK2A1, DRD2, EGFR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK | 2.20835 |
[BP] GO:0021853 | None | DRD1, DRD2 | 2.20835 |
[BP] GO:0010641 | None | F3, SRC | 2.20835 |
[BP] GO:0007598 | None | F10, F3 | 2.20835 |
[BP] GO:1904936 | None | DRD1, DRD2 | 2.20835 |
[BP] GO:0042321 | None | ADORA1, DRD2 | 2.20835 |
[BP] GO:0050730 | None | ADORA1, APP, EGFR, FLT3, PTPN1, SRC | 2.20374 |
[BP] GO:0031100 | animal organ regeneration | AXL, CSNK2A1, EGFR, FLT3 | 2.1867 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, EGFR, MMP2, MMP9 | 2.1867 |
[BP] GO:0050794 | regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 2.17437 |
[BP] GO:0042060 | None | ALOX15, EGFR, PPARA, SMAD3 | 2.1681 |
[BP] GO:2000116 | regulation of cysteine-type endopeptidase activity | CSNK2A1, F3, MMP9, SMAD3, SRC, XDH | 2.16102 |
[BP] GO:0006928 | movement of cell or subcellular component | APP, AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, PRKCA, SRC, TEK | 2.15416 |
[BP] GO:0030518 | intracellular steroid hormone receptor signaling pathway | AR, NR3C1, PGR, SRC | 2.15092 |
[BP] GO:0018958 | None | AKR1B1, DRD1, DRD2, TYR | 2.15092 |
[BP] GO:0051098 | regulation of binding | APP, AURKB, MET, MMP9, PPARA, SMAD3, SRC | 2.1482 |
[BP] GO:0008217 | None | ADORA1, AR, DRD2, PPARA, SMAD3 | 2.14306 |
[BP] GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | FLT3, SRC, TEK | 2.14238 |
[BP] GO:0042743 | hydrogen peroxide metabolic process | CYP1A1, CYP1A2, EGFR | 2.14238 |
[BP] GO:0022617 | extracellular matrix disassembly | MMP1, MMP12, MMP2, MMP9 | 2.13514 |
[BP] GO:0003006 | developmental process involved in reproduction | AR, AXL, CDC25B, CYP19A1, EGFR, HSD17B2, INSR, PGR, SRC | 2.11688 |
[BP] GO:1901890 | None | KDR, SMAD3, TEK | 2.10597 |
[BP] GO:0071276 | cellular response to cadmium ion | CYP1A2, EGFR, MMP9 | 2.10597 |
[BP] GO:0001659 | None | ADORA1, DRD1, DRD2 | 2.10597 |
[BP] GO:0032963 | collagen metabolic process | MMP1, MMP12, MMP2, MMP9 | 2.09975 |
[BP] GO:0045766 | positive regulation of angiogenesis | CYP1B1, F3, KDR, PRKCA, TEK | 2.08715 |
[BP] GO:1901888 | regulation of cell junction assembly | KDR, SMAD3, SRC, TEK | 2.08132 |
[BP] GO:0003018 | None | ADORA1, DRD1, EGFR, SRC, TEK | 2.07715 |
[BP] GO:0048729 | tissue morphogenesis | AR, CA2, CA9, EGFR, MET, SMAD3, SRC | 2.07715 |
[BP] GO:0022029 | None | DRD1, DRD2, EGFR | 2.07715 |
[BP] GO:0071396 | cellular response to lipid | AR, AXL, EGFR, FLT3, NR3C1, RORC, SRC | 2.07715 |
[BP] GO:0021843 | None | DRD1, DRD2 | 2.07715 |
[BP] GO:1990535 | None | APP, INSR | 2.07715 |
[BP] GO:0021830 | None | DRD1, DRD2 | 2.07715 |
[BP] GO:0002933 | lipid hydroxylation | CYP1A1, CYP3A4 | 2.07715 |
[BP] GO:0021826 | None | DRD1, DRD2 | 2.07715 |
[BP] GO:2001300 | lipoxin metabolic process | ALOX15, ALOX5 | 2.07715 |
[BP] GO:0016098 | monoterpenoid metabolic process | CYP1A2, CYP3A4 | 2.07715 |
[BP] GO:0032787 | None | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA | 2.07214 |
[BP] GO:0009894 | regulation of catabolic process | ADORA1, CSNK2A1, EGFR, HSPA1A, INSR, KDR, MET, PPARA, PRKCA, PTPN1, SMAD3 | 2.05139 |
[BP] GO:0090218 | positive regulation of lipid kinase activity | FLT3, SRC, TEK | 2.05103 |
[BP] GO:0006775 | fat-soluble vitamin metabolic process | CBR1, CYP1A1, CYP3A4 | 2.05103 |
[BP] GO:0010907 | None | INSR, PPARA, SRC | 2.05103 |
[BP] GO:0106027 | None | APP, IGF1R, INSR | 2.05103 |
[BP] GO:0010595 | positive regulation of endothelial cell migration | KDR, MET, PRKCA, TEK | 2.04581 |
[BP] GO:0042058 | None | ADORA1, APP, EGFR, MMP9 | 2.02932 |
[BP] GO:0001938 | None | F3, KDR, PRKCA, TEK | 2.02932 |
[BP] GO:0044259 | multicellular organismal macromolecule metabolic process | MMP1, MMP12, MMP2, MMP9 | 2.02932 |
[BP] GO:0000902 | cell morphogenesis | AR, AXL, MET, SRC, TEK | 2.02714 |
[BP] GO:0002793 | None | ACHE, ADORA1, DRD2, EGFR, MMP12, SRC | 2.02631 |
[BP] GO:1901617 | organic hydroxy compound biosynthetic process | AKR1B1, ALOX15, CYP19A1, CYP3A4, TYR | 2.01773 |
[CC] GO:0005886 | plasma membrane | ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, EGFR, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, PIM1, PRKCA, PTPN1, SMAD3, SRC, TEK | 3.24404 |
[CC] GO:0031226 | intrinsic component of plasma membrane | ADORA1, ADORA3, APP, AXL, CA4, DRD1, DRD2, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK | 2.88628 |
[CC] GO:0044459 | plasma membrane part | ADORA1, ADORA3, ALOX15, APP, AXL, CA2, CA4, CA9, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, SRC, TEK | 2.76255 |
[CC] GO:0016020 | membrane | ACHE, ADORA1, ADORA3, ALOX15, ALOX5, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, F10, F3, FLT3, FUT7, GPR35, HSD17B2, IGF1R, INSR, KDR, MET, MMP2, NR3C2, PGR, PIM1, PRKCA, PTPN1, SMAD3, SRC, TEK, TYR | 2.65053 |
[CC] GO:0016323 | basolateral plasma membrane | ADORA1, CA2, CA4, CA9, EGFR, TEK | 2.59418 |
[CC] GO:0031233 | None | CA4, F10, F3 | 2.55012 |
[CC] GO:0044444 | cytoplasmic part | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AR, AURKB, CA1, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PRKCA, PTPN1, SMAD3, SRC, TYR, XDH | 2.5286 |
[CC] GO:0031253 | None | ADORA1, CA4, CA9, DRD1, DRD2, INSR, SRC | 2.32482 |
[CC] GO:0097443 | sorting endosome | KDR, PTPN1 | 2.07715 |
[MF] GO:0046914 | transition metal ion binding | ALOX15, ALOX5, APP, AR, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, TYR, XDH | 17.5655 |
[MF] GO:0043167 | ion binding | ACHE, ALOX15, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TYR, XDH | 12.9154 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 | 12.4315 |
[MF] GO:0003824 | catalytic activity | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F10, F3, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PRKCA, PTPN1, SRC, TEK, TYR, XDH | 10.3446 |
[MF] GO:0008270 | zinc ion binding | AR, CA1, CA12, CA2, CA4, CA6, CA7, CA9, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, PRKCA, PTPN1, RORC, SMAD3 | 9.09561 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 | 8.10168 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 7.74801 |
[MF] GO:0043169 | cation binding | ACHE, ALOX15, ALOX5, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, F10, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, TYR, XDH | 7.55768 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 | 7.17006 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 7.02974 |
[MF] GO:0008144 | drug binding | ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PRKCA, SRC, TEK | 6.84654 |
[MF] GO:0046872 | metal ion binding | ALOX15, ALOX5, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, TYR, XDH | 6.00558 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, AR, AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK | 5.70969 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 5.70969 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 | 5.58298 |
[MF] GO:0042562 | hormone binding | ACHE, AR, EGFR, HSD17B1, IGF1R, INSR, NR3C1 | 5.54987 |
[MF] GO:0005496 | steroid binding | AR, CYP3A4, HSD17B1, NR3C1, NR3C2, PGR, RORC | 5.51906 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK | 5.37806 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 | 5.36132 |
[MF] GO:0008289 | lipid binding | ALOX15, AR, AXL, CYP3A4, F10, F3, FABP3, FABP4, HSD17B1, NR3C1, NR3C2, PGR, PPARA, RORC | 5.2208 |
[MF] GO:0003707 | steroid hormone receptor activity | AR, NR3C1, NR3C2, PGR, PPARA, RORC | 5.11644 |
[MF] GO:0005506 | iron ion binding | ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH | 5.00593 |
[MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, AR, AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3, TEK | 4.98262 |
[MF] GO:0004872 | receptor activity | ADORA1, ADORA3, AR, AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK | 4.97248 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, HSD17B2, TYR, XDH | 4.85486 |
[MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, AR, AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK | 4.76847 |
[MF] GO:0016829 | lyase activity | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 | 4.61041 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK | 4.53221 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 | 4.2772 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC | 4.14511 |
[MF] GO:0016301 | kinase activity | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK | 4.11799 |
[MF] GO:0140096 | catalytic activity, acting on a protein | AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F10, F3, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PRKCA, PTPN1, SRC, TEK | 4.03237 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR | 4.02837 |
[MF] GO:0032403 | protein complex binding | ACHE, ADORA1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC | 3.75714 |
[MF] GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | CYP1A2, CYP3A4, XDH | 3.50092 |
[MF] GO:0004716 | signal transducer, downstream of receptor, with protein tyrosine kinase activity | EGFR, INSR, KDR | 3.50092 |
[MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK | 3.38869 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC | 3.38425 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2, XDH | 3.25338 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC | 3.22249 |
[MF] GO:0043168 | anion binding | ALOX15, APP, AURKB, AXL, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, XDH | 3.11102 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR | 2.96544 |
[MF] GO:0019899 | enzyme binding | APP, AR, AURKB, CDC25B, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, F3, HSPA1A, MET, NR3C1, PGR, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK | 2.94869 |
[MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | AR, PGR, PPARA, RORC | 2.7723 |
[MF] GO:0004879 | nuclear receptor activity | AR, PGR, PPARA, RORC | 2.7723 |
[MF] GO:0031072 | heat shock protein binding | ADORA1, CSNK2A1, HSPA1A, KDR, NR3C1 | 2.70419 |
[MF] GO:0070576 | vitamin D 24-hydroxylase activity | CYP1A1, CYP3A4 | 2.59728 |
[MF] GO:0017171 | serine hydrolase activity | ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 | 2.54498 |
[MF] GO:0099600 | transmembrane receptor activity | ADORA1, ADORA3, AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK | 2.50812 |
[MF] GO:0004888 | transmembrane signaling receptor activity | ADORA1, ADORA3, AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK | 2.50812 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2 | 2.49596 |
[MF] GO:0005518 | collagen binding | ACHE, MMP12, MMP9, SMAD3 | 2.41652 |
[MF] GO:0036094 | small molecule binding | ADORA1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, XDH | 2.39525 |
[MF] GO:0005524 | ATP binding | AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK | 2.37336 |
[MF] GO:0034875 | caffeine oxidase activity | CYP1A2, CYP3A4 | 2.36959 |
[MF] GO:0051425 | None | APP, INSR | 2.36959 |
[MF] GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | CYP1A2, CYP3A4 | 2.36959 |
[MF] GO:0019838 | growth factor binding | EGFR, IGF1R, INSR, KDR, TEK | 2.35628 |
[MF] GO:0032559 | adenyl ribonucleotide binding | AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK | 2.29213 |
[MF] GO:0030554 | adenyl nucleotide binding | AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK | 2.27106 |
[MF] GO:0101020 | estrogen 16-alpha-hydroxylase activity | CYP1A1, CYP3A4 | 2.20835 |
[MF] GO:0043559 | insulin binding | IGF1R, INSR | 2.20835 |
[MF] GO:0097159 | organic cyclic compound binding | ADORA1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 2.19309 |
[MF] GO:0043548 | phosphatidylinositol 3-kinase binding | AXL, IGF1R, INSR | 2.17557 |
[MF] GO:0005158 | None | IGF1R, PTPN1, SRC | 2.10597 |
[MF] GO:0051879 | Hsp90 protein binding | CSNK2A1, KDR, NR3C1 | 2.07715 |
[MF] GO:0004252 | None | F10, F3, MMP1, MMP12, MMP2, MMP9 | 2.07715 |
[MF] GO:0004064 | arylesterase activity | CA1, CA2 | 2.07715 |
[MF] GO:0048037 | cofactor binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, SRC, XDH | 2.05103 |
[MF] GO:0008395 | steroid hydroxylase activity | CYP19A1, CYP1A1, CYP3A4 | 2.01924 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA2, CA4, CA7, CA6, CA9, CA14 | 13.6364 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, INSR, HSD17B1, HSD17B2, CYP1A1, CYP1B1, CYP19A1, IGF1R | 9.6286 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, SMAD3, CSNK2A1, SRC, INSR, MET, EGFR, IGF1R | 8.3818 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP3A4, CYP19A1 | 7.6383 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | SRC, INSR, KDR, PRKCA, TEK, DRD2, MET, EGFR, IGF1R | 6.2025 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | SRC, MMP2, KDR, PRKCA, MMP9, MET, EGFR, IGF1R | 5.2716 |
Pathways in cancer_Homo sapiens_hsa05200 | AR, SMAD3, FLT3, MMP1, MMP2, PRKCA, MMP9, MET, EGFR, IGF1R | 5.0737 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9, EGFR | 5.3188 |
Ras signaling pathway_Homo sapiens_hsa04014 | INSR, KDR, PRKCA, TEK, MET, EGFR, IGF1R | 3.9867 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | CBR1, CYP1A2, CYP1A1, CYP1B1, CYP3A4 | 4.2264 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | SMAD3, MMP2, PIM1, PRKCA, F3 | 3.7496 |
Endocytosis_Homo sapiens_hsa04144 | SMAD3, SRC, KDR, MET, EGFR, IGF1R, HSPA1A | 3.7496 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | SRC, MMP2, MMP9, EGFR, HSPA1A | 3.7496 |
Gap junction_Homo sapiens_hsa04540 | SRC, PRKCA, DRD1, DRD2, EGFR | 3.9508 |
Metabolic pathways_Homo sapiens_hsa01100 | CBR1, ALOX15, AKR1B1, TYR, CYP3A4, CYP19A1, FUT7, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, XDH | 3.6434 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | CBR1, CYP1A2, CYP1A1, CYP1B1, CYP3A4 | 4.0224 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | INSR, PRKCA, TEK, EGFR, IGF1R | 3.7423 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | PIM1, CYP1B1, PRKCA, MMP9, MET, EGFR, CDC25B | 3.4595 |
Focal adhesion_Homo sapiens_hsa04510 | SRC, KDR, PRKCA, MET, EGFR, IGF1R | 3.4595 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | INSR, KDR, PRKCA, TEK, MET, EGFR, IGF1R | 3.154 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | GPR35, ADORA3, ADORA1, DRD1, NR3C1, DRD2 | 2.8265 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2, PRKCA, EGFR | 2.8897 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 3.2783 |
Serotonergic synapse_Homo sapiens_hsa04726 | APP, ALOX5, ALOX15, PRKCA | 2.6119 |
FoxO signaling pathway_Homo sapiens_hsa04068 | SMAD3, INSR, EGFR, IGF1R | 2.361 |
MAPK signaling pathway_Homo sapiens_hsa04010 | DUSP3, PRKCA, EGFR, CDC25B, HSPA1A | 2.2827 |
Hepatitis B_Homo sapiens_hsa05161 | SMAD3, SRC, PRKCA, MMP9 | 2.2896 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, INSR, ADORA1 | 2.3959 |
VEGF signaling pathway_Homo sapiens_hsa04370 | SRC, KDR, PRKCA | 2.3163 |
Glioma_Homo sapiens_hsa05214 | PRKCA, EGFR, IGF1R | 2.2896 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | INSR, IGF1R, HSPA1A | 2.2896 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | CBR1, ALOX5, ALOX15 | 2.3095 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | INSR, PRKCA, NR3C2 | 2.8139 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 2.024 |
cAMP signaling pathway_Homo sapiens_hsa04024 | ADORA1, DRD1, DRD2, PPARA | 1.9069 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | FLT3, MET, EGFR | 2.2827 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, CYP1B1 | 2.7972 |
Melanoma_Homo sapiens_hsa05218 | MET, EGFR, IGF1R | 2.2358 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1, CYP3A4 | 2.2896 |
Prostate cancer_Homo sapiens_hsa05215 | AR, EGFR, IGF1R | 1.9965 |
ErbB signaling pathway_Homo sapiens_hsa04012 | SRC, PRKCA, EGFR | 2.0145 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | PGR, CDC25B, IGF1R | 1.9069 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET, EGFR | 2.279 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1, PRKCA, DRD1 | 1.9788 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, INSR, PPARA | 1.8047 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2, CYP3A4 | 3.1489 |
Oocyte meiosis_Homo sapiens_hsa04114 | AR, PGR, IGF1R | 1.6927 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET, EGFR | 1.5737 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, ADORA1, PRKCA | 1.714 |
Dopaminergic synapse_Homo sapiens_hsa04728 | PRKCA, DRD1, DRD2 | 1.6438 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | MMP2, PRKCA, MMP9 | 1.7261 |
Wnt signaling pathway_Homo sapiens_hsa04310 | SMAD3, CSNK2A1, PRKCA | 1.5608 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC, PRKCA | 1.5737 |
Phospholipase D signaling pathway_Homo sapiens_hsa04072 | INSR, PRKCA, EGFR | 1.5589 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | SRC, PRKCA, EGFR | 1.4647 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | ADORA3, INSR, ADORA1 | 1.4275 |
Calcium signaling pathway_Homo sapiens_hsa04020 | PRKCA, DRD1, EGFR | 1.3668 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE, PRKCA | 1.0427 |
Measles_Homo sapiens_hsa05162 | CSNK2A1, HSPA1A | 0.9169 |
Parkinson's disease_Homo sapiens_hsa05012 | DRD1, DRD2 | 0.8986 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | SRC, PRKCA | 1.1244 |
Melanogenesis_Homo sapiens_hsa04916 | PRKCA, TYR | 1.1138 |
Hepatitis C_Homo sapiens_hsa05160 | PPARA, EGFR | 0.9289 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | SRC, PRKCA | 1.0056 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | INSR, IGF1R | 1.1465 |
AMPK signaling pathway_Homo sapiens_hsa04152 | INSR, IGF1R | 0.9776 |
HTLV-I infection_Homo sapiens_hsa05166 | SMAD3 | 0.2524 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1, INSR | 0.9055 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | SMAD3, IGF1R | 0.8986 |
Choline metabolism in cancer_Homo sapiens_hsa05231 | PRKCA, EGFR | 1.1113 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, HSPA1A | 0.6953 |
Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5, HSPA1A | 1.0056 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | INSR, PPARA | 0.8713 |
Cell cycle_Homo sapiens_hsa04110 | SMAD3, CDC25B | 0.9776 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | SRC, EGFR | 0.6714 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1, TEK | 1.1754 |
Viral carcinogenesis_Homo sapiens_hsa05203 | SRC | 0.3179 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2, PRKCA | 1.1353 |
Alcoholism_Homo sapiens_hsa05034 | DRD1, DRD2 | 0.777 |
Influenza A_Homo sapiens_hsa05164 | PRKCA, HSPA1A | 0.7891 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC, PRKCA | 1.1878 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.3447 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.3552 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | HSPA1A | 0.3656 |
Tuberculosis_Homo sapiens_hsa05152 | SRC | 0.3544 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | SRC | 0.344 |
Alzheimer's disease_Homo sapiens_hsa05010 | APP | 0.3656 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIM1 | 0.3824 |
Hippo signaling pathway_Homo sapiens_hsa04390 | SMAD3 | 0.3903 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | PRKCA | 0.3987 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2, PRKCA | 1.3098 |
Spliceosome_Homo sapiens_hsa03040 | HSPA1A | 0.4276 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | SRC, MET | 1.273 |
Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | PRKCA | 0.4276 |
Pancreatic cancer_Homo sapiens_hsa05212 | SMAD3, EGFR | 1.3725 |
Amphetamine addiction_Homo sapiens_hsa05031 | PRKCA, DRD1 | 1.3668 |
Platelet activation_Homo sapiens_hsa04611 | SRC | 0.4544 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.4431 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | PRKCA, EGFR | 1.4647 |
Long-term depression_Homo sapiens_hsa04730 | PRKCA, IGF1R | 1.4314 |
Complement and coagulation cascades_Homo sapiens_hsa04610 | F10, F3 | 1.2685 |
TNF signaling pathway_Homo sapiens_hsa04668 | MMP9 | 0.4827 |
Vascular smooth muscle contraction_Homo sapiens_hsa04270 | PRKCA | 0.4573 |
Glutamatergic synapse_Homo sapiens_hsa04724 | PRKCA | 0.4728 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | FLT3, PIM1 | 1.4604 |
Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | SMAD3 | 0.5002 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.5078 |
Bile secretion_Homo sapiens_hsa04976 | CA2, CYP3A4 | 1.3374 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | SMAD3, RORC | 1.3787 |
Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | PRKCA | 0.5196 |
Amoebiasis_Homo sapiens_hsa05146 | PRKCA | 0.5078 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP1A2, CYP3A4 | 1.3547 |
Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | PRKCA | 0.5096 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.518 |
Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | PRKCA | 0.5078 |
Circadian entrainment_Homo sapiens_hsa04713 | PRKCA | 0.518 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1 | 0.5196 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.5294 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.4387 |
TGF-beta signaling pathway_Homo sapiens_hsa04350 | SMAD3 | 0.5381 |
Salivary secretion_Homo sapiens_hsa04970 | PRKCA | 0.5294 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.5294 |
Insulin secretion_Homo sapiens_hsa04911 | PRKCA | 0.5369 |
Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | PRKCA | 0.545 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.5391 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | SMAD3 | 0.5781 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | SRC | 0.5799 |
Antigen processing and presentation_Homo sapiens_hsa04612 | HSPA1A | 0.561 |
Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | PRKCA | 0.5914 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.5837 |
Long-term potentiation_Homo sapiens_hsa04720 | PRKCA | 0.5995 |
Thyroid hormone synthesis_Homo sapiens_hsa04918 | PRKCA | 0.5817 |
Renal cell carcinoma_Homo sapiens_hsa05211 | MET | 0.5995 |
Cocaine addiction_Homo sapiens_hsa05030 | DRD1, DRD2 | 1.5589 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.6003 |
mTOR signaling pathway_Homo sapiens_hsa04150 | PRKCA | 0.6182 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5995 |
Colorectal cancer_Homo sapiens_hsa05210 | SMAD3 | 0.6091 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | CYP3A4, XDH | 1.5809 |
Legionellosis_Homo sapiens_hsa05134 | HSPA1A | 0.649 |
Endometrial cancer_Homo sapiens_hsa05213 | EGFR | 0.6635 |
Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | PRKCA | 0.649 |
Vibrio cholerae infection_Homo sapiens_hsa05110 | PRKCA | 0.6674 |
Malaria_Homo sapiens_hsa05144 | MET | 0.6755 |
Type II diabetes mellitus_Homo sapiens_hsa04930 | INSR | 0.6796 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.8765 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | PRKCA | 0.6842 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.7471 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.83 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 2.0371 |
Prion diseases_Homo sapiens_hsa05020 | HSPA1A | 0.7891 |
African trypanosomiasis_Homo sapiens_hsa05143 | PRKCA | 0.7891 |
Dorso-ventral axis formation_Homo sapiens_hsa04320 | EGFR | 0.8713 |
Tyrosine metabolism_Homo sapiens_hsa00350 | TYR | 0.7891 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.8248 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.8752 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.8339 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.8713 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 3.154 |